Lataa...
Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters
BACKGROUND: Efflux transporters like MDR1 and MRP2 may modulate the pharmacokinetics of about 50 % of all drugs. It is currently unknown how much of the variation in the activities of important drug membrane transporters like MDR1 or MRP2 is determined by genetic or by environmental factors. In this...
Tallennettuna:
Julkaisussa: | Genome Med |
---|---|
Päätekijät: | , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
BioMed Central
2016
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5101708/ https://ncbi.nlm.nih.gov/pubmed/27825374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-016-0372-2 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|